Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Hansoh Pharmaceutical
Pharmaceutical Preparation ManufacturingChinaHKSE: 3692.HK
Last verified 2 months agohspharm.com
Hansoh Pharmaceutical Group Company Limited, commonly known as Hansoh Pharmaceutical, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in China. Established in 1995, the company has made significant strides in developing innovative therapies, particularly in oncology, central nervous system disorders, and autoimmune diseases.
With a strong operational presence across various regions in China and expanding internationally, Hansoh Pharmaceutical is renowned for its commitment to research and development. The company offers a diverse portfolio of products, including high-quality generic drugs and proprietary medicines, distinguished by their efficacy and safety profiles.
Recognised for its rapid growth and market position, Hansoh Pharmaceutical has achieved notable milestones, including numerous product approvals and partnerships that enhance its global reach. As a key contributor to the pharmaceutical landscape, Hansoh continues to focus on advancing healthcare solutions that meet the evolving needs of patients worldwide.
49
DitchCarbon score
+7 vs industry average
Hansoh Pharmaceutical’s score of 49 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Hansoh Pharmaceutical?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very High
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Hansoh Pharmaceutical's reported carbon emissions
Hansoh Pharmaceutical, a Pharmaceutical Preparation Manufacturing company based in China, reported total carbon emissions of approximately 222,077,940 kg CO2e in 2025. This includes Scope 1 emissions of 11,833,890 kg CO2e, Scope 2 emissions of 97,828,710 kg CO2e, and Scope 3 emissions of 93,115,140 kg CO2e. In 2024, their total emissions were approximately 157,115,050 kg CO2e, comprising 13,163,250 kg CO2e from Scope 1, 88,227,050 kg CO2e from Scope 2, and 55,724,800 kg CO2e from Scope 3. For 2023, Hansoh Pharmaceutical reported Scope 1 emissions of 10,546,850 kg CO2e and Scope 2 emissions of 81,565,210 kg CO2e.
The company has set a near-term intensity reduction target to decrease greenhouse gas emissions per unit of revenue from Scope 1 and Scope 2 by 40% by 2030, using 2021 as the base year. Additionally, Hansoh Pharmaceutical aims to reduce comprehensive energy consumption per unit of revenue by 20% by 2030, also using 2021 as the base year. Emissions data and reduction initiatives are cascaded from Hansoh Pharmaceutical Group Company Limited.
Assessing Hansoh Pharmaceutical as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Hansoh Pharmaceutical and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Hansoh Pharmaceutical’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Hansoh Pharmaceutical2 months ago
49
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more